Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
REVENUES:
Total revenues	$ 565,464	$ 753,108
OPERATING EXPENSES:
Research and development	4,741,130	3,922,665
General and administrative	10,026,627	7,791,600
TOTAL OPERATING EXPENSES	14,767,757	11,714,265
OPERATING LOSS	(14,202,293)	(10,961,157)
OTHER INCOME (EXPENSE):
Interest income	405,239	297,800
Interest and other expense	(994,979)	(1,145,761)
Change in fair value of warrant liability	(5,710,362)	12,705,598
TOTAL OTHER INCOME (EXPENSE)	(6,300,102)	11,857,637
INCOME (LOSS) BEFORE INCOME TAXES	(20,502,395)	896,480
Income taxes
NET INCOME (LOSS)	(20,502,395)	896,480
Preferred dividends and beneficial conversion feature	(13,750,806)
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS	$ (34,253,201)	$ 896,480
Net income (loss) per common share - basic (in dollars per share)	$ (3.84)	$ 0.10
Net income (loss) per common share - diluted (in dollars per share)	$ (3.84)	$ 0.10
Weighted average shares of common shares - basic (in shares)	8,916,190	8,733,220
Weighted average shares of common shares - diluted (in shares)	8,916,190	8,733,220
Grant [Member]
REVENUES:
Total revenues	$ 565,464	$ 753,108